Can Fite Biopharma Ltd ADR (CANF) — Long-term Investment Intensity
Can Fite Biopharma Ltd ADR (CANF) has a Long-term Investment Intensity of 9.9% as of September 2018. Long-term investments of $1.08 Million represent 9.9% of total assets of $10.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Can Fite Biopharma Ltd ADR to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Can Fite Biopharma Ltd ADR Long-term Investment Intensity (2017–2017)
This chart shows how Can Fite Biopharma Ltd ADR's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of September 2018, the intensity stands at 9.9%, reflecting long-term investments of $1.08 Million against total assets of $10.82 Million USD. Explore cash flow to debt ratio of Can Fite Biopharma Ltd ADR to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Can Fite Biopharma Ltd ADR (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for Can Fite Biopharma Ltd ADR from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Can Fite Biopharma Ltd ADR market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 11.7% | $914.66K | $7.83 Million | — |